Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

This review aims to assess the benefits and harms of GLP-1 receptor agonists to treat diabetes in people with CKD.

This is a protocol.